13.07.2015 Views

The Genom of Homo sapiens.pdf

The Genom of Homo sapiens.pdf

The Genom of Homo sapiens.pdf

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

α-SYNUCLEIN EXPRESSION AND PD 415gus J., Engelender S., Ross C.A., Berger K., Schols L., SchulzJ.B., Riess O., and Kruger R. 2003. Identification and functionalcharacterization <strong>of</strong> a novel R621C mutation in the synphilin-1gene in Parkinson’s disease. Hum. Mol. Genet. 12:1223.Masliah E., Rockenstein E., Veinbergs I., Mallory M.,Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L.2000. Dopaminergic loss and inclusion body formation in alpha-synucleinmice: Implications for neurodegenerative disorders.Science 287: 1265.Mizuta I., Nishimura M., Mizuta E., Yamasaki S., Ohta M., andKuno S. 2002. Meta-analysis <strong>of</strong> alpha synuclein/ NACP polymorphismin Parkinson’s disease in Japan. J. Neurol. Neurosurg.Psychiatry 73: 350.Okladnova O., Syagailo Y.V., Tranitz M., Stober G., RiedererP., Mossner R., and Lesch K.P. 1998. A promoter-associatedpolymorphic repeat modulates PAX-6 expression in humanbrain. Biochem. Biophys. Res. Commun. 248: 402.Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., HardyJ., and Wolozin B. 1999. α-Synuclein shares physical andfunctional homology with 14-3-3 proteins. J. Neurosci. 19:5782.Parsian A., Racette B., Zhang Z.H., Chakraverty S., Rundle M.,Goate A., and Perlmutter J.S. 1998. Mutation, sequence analysis,and association studies <strong>of</strong> alpha-synuclein in Parkinson’sdisease. Neurology 51: 1757.Peters D.G., Kassam A., St. Jean P.L., Yonas H., and FerrellR.E. 1999. Functional polymorphism in the matrix metalloproteinase-9promoter as a potential risk factor for intracranialaneurysm. Stroke 30: 2612.Pollanen M.S., Dickson D.W., and Bergeron C. 1993. Pathologyand biology <strong>of</strong> the Lewy body. J. Neuropathol. Exp. Neurol.52: 183.Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., DehejiaA., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., StenroosE.S., Chandrasekharappa S., Athanassiadou A., PapapetropoulosT., Johnson W.G., Lazzarini A.M., DuvoisinR.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. 1997. Mutationin the alpha-synuclein gene identified in families withParkinson’s disease. Science 276: 2045.Rideout H.J., Dietrich P., Savalle M., Dauer W.T., and StefanisL. 2003. Regulation <strong>of</strong> alpha-synuclein by bFGF in culturedventral midbrain dopaminergic neurons. J. Neurochem. 84:803.Searle S. and Blackwell J.M. 1999. Evidence for a functional repeatpolymorphism in the promoter <strong>of</strong> the human NRAMP1gene that correlates with autoimmune versus infectious diseasesusceptibility. J. Med. Genet. 36: 295.Shimajiri S., Arima N., Tanimoto A., Murata Y., Hamada T.,Wang K.Y., and Sasaguri Y. 1999. Shortened microsatellited(CA)21 sequence down-regulates promoter activity <strong>of</strong> matrixmetalloproteinase 9 gene. FEBS Lett. 455: 70.Singleton A.B., Farrer M., Johnson J., Singleton A., Hauge S.,Kachergus J., Hulihan M., Peuralinna T., Dutra A., NussbaumR., Lincoln S., Crawley A., Hanson M., Maraganore D., AdlerC., Cookson M.R., Muenter M., Baptista M., Miller D., BlancatoJ., Hardy J., and Gwinn-Hardy K. 2003. alpha-Synucleinlocus triplication causes Parkinson’s disease. Science 302:841.Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q.,Jakes R., and Goedert M. 1997. Alpha-synuclein in Lewybodies. Nature 388: 839.Stefanis L., Kholodilov N., Rideout H.J., Burke R.E., andGreene L.A. 2001. Synuclein-1 is selectively up-regulated inresponse to nerve growth factor treatment in PC12 cells. J.Neurochem. 76: 1165.Tan E.K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J.,and Ashizawa T. 2000. Polymorphism <strong>of</strong> NACP-Rep1 inParkinson’s disease: An etiologic link with essential tremor?Neurology 54: 1195.Tan E.K., Tan C., Shen H., Chai A., Lum S.Y., Teoh M.L., YihY., Wong M.C., and Zhao Y. 2003. Alpha synuclein promoterand risk <strong>of</strong> Parkinson’s disease: Microsatellite and allelic sizevariability. Neurosci. Lett. 336: 70.Tanji K., Imaizumi T., Yoshida H., Mori F., Yoshimoto M.,Satoh K., and Wakabayashi K. 2001. Expression <strong>of</strong> alphasynucleinin a human glioma cell line and its up-regulation byinterleukin-1beta. Neuroreport 12: 1909.Tanji K., Mori F., Imaizumi T., Yoshida H., Matsumiya T.,Tamo W., Yoshimoto M., Odagiri H., Sasaki M., TakahashiH., Satoh K., and Wakabayashi K. 2002. Upregulation <strong>of</strong> alpha-synucleinby lipopolysaccharide and interleukin-1 in humanmacrophages. Pathol. Int. 52: 572.Tanner C.M. and Goldman S.M. 1996. Epidemiology <strong>of</strong> Parkinson’sdisease. Neurol. Clin. 14: 317.Touchman J.W., Dehejia A., Chiba-Falek O., Cabin D.E.,Schwartz J.R., Orrison B.M., Polymeropoulos M.H., andNussbaum R.L. 2001. Human and mouse alpha-synucleingenes: Comparative genomic sequence analysis and identification<strong>of</strong> a novel gene regulatory element. <strong>Genom</strong>e Res. 11:78.Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., YoshimotoM., Otero D.A., Kondo J., Ihara Y., and Saitoh T. 1993.Molecular cloning <strong>of</strong> cDNA encoding an unrecognized component<strong>of</strong> amyloid in Alzheimer disease. Proc. Natl. Acad.Sci. 90: 11282.Valente E.M., Bentivoglio A.R., Dixon P.H., Ferraris A., IalongoT., Frontali M., Albanese A., and Wood N.W. 2001.Localization <strong>of</strong> a novel locus for autosomal recessive earlyonsetParkinsonism, PARK6, on human chromosome 1p35-p36. Am. J. Hum. Genet. 68: 895.van Duijn C.M., Dekker M.C., Bonifati V., Galjaard R.J.,Houwing-Duistermaat J.J., Snijders P.J., Testers L., BreedveldG.J., Horstink M., Sandkuijl L.A., van Swieten J.C.,Oostra B.A., and Heutink P. 2001. Park7, a novel locus for autosomalrecessive early-onset Parkinsonism, on chromosome1p36. Am. J. Hum. Genet. 69: 629.Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., JakowecM., and Przedborski S. 2000. Alpha-synuclein up-regulationin substantia nigra dopaminergic neurons following administration<strong>of</strong> the Parkinsonian toxin MPTP. J. Neurochem. 74:721.Xia Y., Rohan de Silva H.A., Rosi B.L., Yamaoka L.H., RimmlerJ.B., Pericak-Vance M.A., Roses A.D., Chen X., MasliahE., DeTeresa R., Iwai A., Sundsmo M., Thomas R.G., H<strong>of</strong>stetterC.R., Gregory E., Hansen L.A., Katzman R., Thal L.J.,and Saitoh T. 1996. Genetic studies in Alzheimer’s diseasewith an NACP/alpha-synuclein polymorphism. Ann. Neurol.40: 207.Xu Z.P., Tsuji T., Riordan J.F., and Hu G.F. 2003. Identificationand characterization <strong>of</strong> an angiogenin-binding DNA sequencethat stimulates luciferase reporter gene expression. Biochemistry42: 121.Yamada N., Yamaya M., Okinaga S., Nakayama K., SekizawaK., Shibahara S., and Sasaki H. 2000. Microsatellite polymorphismin the heme oxygenase-1 gene promoter is associatedwith susceptibility to emphysema. Am. J. Hum. Genet.66: 187.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!